Tuesday, October 8, 2024
Coronavirus
Economic Activity
Education
Financial Services
Food & Agriculture
Government
Health Services
Lists
Manufacturing
Nonprofit
Real Estate
Small Business

TOPICS

Home Tags Immunoinformatics

Tag: Immunoinformatics

EPIVAX AND CUBRC have been awarded a two-year, $1 million federal contract from the U.S. Food and Drug Administration to establish best practices and procedures for assessing generic peptides and related impurities for immunogenic potential. EpiVax CEO and Chief Science Officer Dr. Anne S. De Groot said generic peptides drugs are a quickly growing market. / PBN FILE PHOTO/MICHAEL SALERNO

EpiVax and CUBRC win $1M FDA contract to establish best practices...

Government
PROVIDENCE – EpiVax Inc. and CUBRC Inc. have been awarded a two-year, $1 million federal contract from the U.S. Food and Drug Administration to...
FAST SEQUENCING: Dr. Anne S. De Groot, EpiVax Inc. CEO and chief strategy officer, says the Providence company has spent the past 20 years developing immunoinformatics tools. EpiVax spinoff EpiVax Oncology will use those tools along with fast sequencing to design cancer vaccines specific to individual patients. / PBN PHOTO/MICHAEL SALERNO

Renowned vaccine researcher Dr. Anne S. De Groot is ready to...

Entrepreneurship
In 1997, Dr. Anne S. De Groot founded EpiVax Inc. in ­Providence, backed by a Small Business Innovation Research grant from the National Institutes...
- Featured Event -

Latest News

SUBSCRIBE TO

PBN's All Access Subscription

PBN subscribers get ahead with unlimited access to PBN news, information, and insights from our editorial team, research and data, webinars and much more.

Subscribe

SIGN UP FOR

PBN's Daily Newsletters

Get PBN's top stories and breaking news every day in your email inbox.

FOLLOW US

@ProvBusNews

Follow PBN for the latest news, insider access and more.

MOST POPULAR

OUR MISSION

Helping you succeed in business since 1986.

ABOUT PBN

© Providence Business News. All Rights Reserved.

Privacy   |   Terms of Use   |   Your Privacy Choices   |   Notice at Collection